UBAP2L and gastric cancer: The results demonstrated that the anti-tumor effect of UBAP2L knockdown was antagonized by overexpression of β-catenin, suggesting that silencing of UBAP2L may restrain proliferation, migration, and invasion of gastric cancer cells by deactivating Wnt/β-catenin signaling.